Home

Eli Lilly (LLY)

794.10
+0.00 (0.00%)
NYSE · Last Trade: May 2nd, 8:13 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Is Novo Nordisk Stock a Buy?fool.com
Via The Motley Fool · May 2, 2025
US Futures Rise As Apple, Amazon, Airbnb Earnings Boost Market Sentiment: S&P 500 Hits Milestone That's Preceded A 100% Win Rate Since 1956, Says Expertbenzinga.com
U.S. stock futures are in the green early Friday, after another winning day for the markets in the regular session on Thursday.
Via Benzinga · May 2, 2025
Where Will Viking Therapeutics Be in 3 Years?fool.com
Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 billion over the coming years.
Via The Motley Fool · May 2, 2025
Market Monitor May 2 ( Microsoft, Meta UP - Eli Lilly DOWN)chartmill.com
Wall Street Rebounds as Microsoft and Meta Impress, Eyes Turn to Jobs Report and Tariff Tensions
Via Chartmill · May 2, 2025
Earnings Scheduled For May 1, 2025benzinga.com
Via Benzinga · May 1, 2025
Explore the top gainers and losers within the S&P500 index in today's session.chartmill.com
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.
Via Chartmill · May 1, 2025
Why Eli Lilly (LLY) Stock Is Nosediving
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 11% in the afternoon session after the company reported weak first quarter 2025 results which included an EPS miss due to lower-than-expected profitability and full-year EPS guidance that missed significantly. On the other hand, Eli Lilly narrowly topped analysts' revenue expectations, fueled by surging demand for Mounjaro and Zepbound, which together drove a 45% year-over-year increase in total sales. Still, this was a softer quarter.
Via StockStory · May 1, 2025
Which S&P500 stocks have an unusual volume on Thursday?chartmill.com
Let's have a look at what is happening on the US markets on Thursday. Below you can find the S&P500 stocks with an unusual volume in today's session.
Via Chartmill · May 1, 2025
What's going on in today's session: S&P500 moverschartmill.com
Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · May 1, 2025
Why Eli Lilly Stock Is Sinking Todayfool.com
Via The Motley Fool · May 1, 2025
8 Health Care Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · May 1, 2025
Thursday's session: gap up and gap down stock in the S&P500 indexchartmill.com
Curious about the S&P500 stocks that are gapping on Thursday? Explore the gap up and gap down stocks in the S&P500 index during today's session.
Via Chartmill · May 1, 2025
Wall Street Eyes 8th Positive Day As S&P 500 Recoups Tariff-Led Losses, Bitcoin Rallies To $97,000: What's Driving Markets Thursday?benzinga.com
Wall Street pushed higher in midday trading, with the S&P 500 on track for its eighth consecutive gain — its longest winning streak since November 2023. The index rose about 1% to 5,560, fully recovering the losses sustained after former President Donald Trump announced trade tariffs on April 2.
Via Benzinga · May 1, 2025
These S&P500 stocks are moving in today's pre-market sessionchartmill.com
Get insights into the top gainers and losers in the S&P500 index of Thursday's pre-market session.
Via Chartmill · May 1, 2025
Mounjaro Maker Eli Lilly Clocks 45% Jump In Q1 Revenue, Cuts 2025 Profit Outlook But Not Due To Tariffsbenzinga.com
Eli Lilly cut its 2025 profit outlook after strong Q1 sales from Mounjaro and Zepbound and a $1.57 billion charge tied to a cancer drug acquisition.
Via Benzinga · May 1, 2025
Eli Lilly Stock Falls After Zepbound Sales Miss, Full-Year Profit Outlook Cutstocktwits.com
The company cut its adjusted earnings per share guidance for the full year to $22.50 to $24.00, down from its previous forecast of $20.78 to $22.28.
Via Stocktwits · May 1, 2025
Beat the Nasdaq With This Cash-Gushing Dividend Stockfool.com
Via The Motley Fool · May 1, 2025
Eli Lilly Slumps 5% On Profit Guidance Cut Despite Mounjaro, Zepbound Beatsinvestors.com
The drugmaker cut its profit guidance for the year, but kept its sales outlook.
Via Investor's Business Daily · May 1, 2025
Eli Lilly (NYSE:LLY) Beats Q1 Sales Targets
Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 45.2% year on year to $12.73 billion. The company expects the full year’s revenue to be around $59.5 billion, close to analysts’ estimates. Its non-GAAP profit of $3.34 per share was 3.4% below analysts’ consensus estimates.
Via StockStory · May 1, 2025
If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?investors.com
Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year?
Via Investor's Business Daily · May 1, 2025
1 Beaten-Down Stock to Buy and Hold for 10 Yearsfool.com
Via The Motley Fool · May 1, 2025
US Stock Futures Rise As Meta, Microsoft Earnings Fuel Optimism: GDP Slump Linked To Tariff Anticipation, Not Recession, Says Analystbenzinga.com
U.S. stock futures rose early Thursday morning, following the robust earnings of two "Mag 7" companies after markets closed on Wednesday.
Via Benzinga · May 1, 2025
Where Is Hims & Hers Stock Headed After Wegovy Tie-Up? Retail Traders Bet On Rebound To Over 2-Month Highstocktwits.com
Needham called the tie-up a “groundbreaking partnership” and said it alleviates investor concerns around Hims’ ability to hit its 2025 weight loss revenue guidance.
Via Stocktwits · May 1, 2025
Eli Lilly Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analystsbenzinga.com
Via Benzinga · May 1, 2025
Nasdaq, Dow Jones Futures Rise On Meta, Microsoft Results: Apple Earnings Loom, Analyst Doubts New Bull Run For Stock Marketsstocktwits.com
Notwithstanding the recent seven-session run, the S&P 500 Index ended April — a historically strong month — with a loss of 0.8%.
Via Stocktwits · April 30, 2025